Decapeptyl diario 0
Sponsors
Instituto Bernabeu S.L., Santiago Dexeus Font Fundacio Privada
Conditions
InfertilityWomen undergoing ovarian stimulation for oocyte donation.infertilitylow ovarian reserve according to Bologna criteria and carriers of androgen receptor polymorphism
Phase 3
A randomized controlled trial comparing sequential of two shots of CFA vs CFA + rFSH for Elective Fertility Preservation. The 2-shot protocol.
CompletedCTIS2023-506162-31-00
Start: 2023-12-12End: 2025-09-09Target: 194Updated: 2024-04-17
Transdermal testosterone pretreatment in poor responders with androgen receptor polymorphism undergoing ICSI: A Randomized Clinical Investigation.
Not yet recruitingCTIS2024-510596-37-01
Target: 100Updated: 2025-10-06
Phase 4
Evaluation of the efficacy of micronized natural progesterone (Seidigestan®) vs GnRH antagonists (Astarté®) in the prevention of LH surge during controlled ovarian stimulation: a randomized clinical trial.
RecruitingCTIS2023-504188-18-00
Start: 2023-11-08Target: 150Updated: 2023-05-09
The impact of ovarian stimulation intensity on embryo euploidy in advanced age women. A randomized controlled trial
RecruitingCTIS2023-507028-22-00
Start: 2023-12-12Target: 110Updated: 2024-07-04
Transdermal testosterone pretreatment in poor responders with androgen receptor polymorphism undergoing ICSI: A Randomized Clinical Investigation.
WithdrawnCTIS2024-510596-37-00
Target: 100Updated: 2024-04-29
The impact of the intensity of ovarian stimulation on embryo quality in predicted suboptimal responders. A randomized controlled trial.
Not yet recruitingCTIS2024-514322-23-00
Target: 110Updated: 2024-09-09
Intranasal nafarelin compared to subcutaneous triptorelin for triggering final oocyte maturation in ovarian stimulation: a non-inferiority randomised controlled clinical trial
Not yet recruitingCTIS2024-516621-31-00
Target: 134Updated: 2024-12-09
Effect of Semaglutide on embryo quality in overweight and obese patients undergoing In Vitro Fertilization. A Randomized Controlled Trial
RecruitingCTIS2025-522525-34-00
Start: 2026-01-19Target: 62Updated: 2025-10-24